BioStock: Stayble Therapeutics recruits VP CMC and Regulatory Affairs
Stayble Therapeutics strengthens the organization by appointing Dr. Sara Richardson in the new role of VP CMC and Regulatory Affairs. Dr. Richardson's expertise and experience in manufacturing issues (CMC) and regulatory applications will be very valuable for the company's future plans and the clinical development of the drug candidate STA363. BioStock reached out to Dr. Richardson for a comment.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se